Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosslyn Data Regulatory News (RDT)

Share Price Information for Rosslyn Data (RDT)

Share Price is delayed by 15 minutes
Get Live Data
1.85    0.00 (0.00%)
Bid:
1.80
Ask:
1.90
Spread: 0.10 (5.556%)
Market Cap: £2.18m
RDT Live PriceLast checked at - London Stock Exchange

Intraday Rosslyn Data Share Chart

Board Changes

14 Mar 2025 07:00

RNS Number : 6440A
Rosslyn Data Technologies PLC
14 March 2025
 

14 March 2025

 

Rosslyn Data Technologies plc

("Rosslyn", the "Group" or the "Company")

 

Board Changes

 

Rosslyn (AIM: RDT), the provider of a leading cloud-based enterprise spend intelligence platform, is pleased to announce the appointment of Dr John Chessher as an Independent Non-Executive Director with immediate effect. John will replace Ginny Warr who has informed the Company of her decision to step down as a Non-Executive Director of the Company due to increased commitments in her executive role. Ginny will step down from the Board on 31 March 2025.

 

John has 30 years' investment industry experience and has held CEO and director-level positions at leading asset management and investment banking firms. He has most notably previously acted as CEO of Cenkos Securities Asia and as Head of Asia Pacific Research at Schroder Investment Management. John is currently a Non-Executive Director of Sunda Energy plc, an AIM-listed exploration and appraisal company focussed on gas assets in Southeast Asia.

 

John is a CFA charter-holder, holds an MA in Engineering Science from Oxford University and DBA, MSc and MBA qualifications from Henley Business School.

 

Following his appointment, John will act as Chair of the Audit and Remuneration Committees.

 

James Appleby, Chairman of Rosslyn, said: "I am delighted to welcome John to the Board of Rosslyn. We look forward to working with him and benefitting from his significant corporate experience. I would also like to thank Ginny for her excellent contribution over the past few years and we wish her well for the future."

 

Enquiries

 

Rosslyn

Paul Watts, Chief Executive Officer

James Appleby, Chairman

+44 (0)20 3285 8008

 

Cavendish Capital Markets Limited (Nominated adviser and Broker)

Stephen Keys/Camilla Hume/George Lawson

+44 (0)20 7220 0500

Gracechurch Group (Financial PR)

Claire Norbury/Anysia Virdi

+44 (0)20 4582 3500

 

 

Further information on Dr John Chessher

 

John Robert Chessher (aged 62) has held the following directorships in the past 5 years:

 

Current Directorships

Previous Directorships held in the past 5 years

Sunda Energy plc

Mind Markets Limited

 

Dr John Chessher does not own any ordinary shares or options over ordinary shares in the Company.

 

There is no further information on Dr John Chessher required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

About Rosslyn

 

Rosslyn (AIM: RDT) provides an award-winning spend intelligence platform. The Rosslyn Platform helps organizations with diverse supply chains mitigate risk and make informed strategic decisions. It leverages automated workflows, artificial intelligence and machine learning to extract and consolidate procurement data providing visibility of complex supplier data, enabling supplier spend savings and delivering rapid ROI. For more information visit www.rosslyn.ai. Investors wishing to contact the Company should email investors@rosslyn.ai.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPKNBPCBKDDND
Date   Source Headline
20th Aug 20195:28 pmRNSHolding(s) in Company
25th Jul 20194:58 pmRNSDirector/PDMR Shareholding
9th Jul 20197:00 amRNSContract Win
17th Jun 20193:04 pmRNSExercise of Options, Director/PDMR Shareholding
30th May 20192:53 pmRNSDirector/PDMR Shareholding
29th May 20197:00 amRNSTrading Update
20th May 20197:00 amRNSBoard Changes
11th Apr 20197:00 amRNSBoard Appointment
9th Apr 20197:00 amRNSLoan Refinancing
25th Feb 20191:54 pmRNSHolding(s) in Company
11th Feb 20197:00 amRNSContract Wins
11th Dec 20183:46 pmRNSHolding(s) in Company
5th Dec 20183:25 pmRNSHolding(s) in Company
5th Dec 20183:23 pmRNSHolding(s) in Company
30th Nov 201812:38 pmRNSDirector/PDMR Shareholding
26th Nov 20187:00 amRNSHalf-year Report
7th Nov 20185:29 pmRNSResult of AGM
5th Nov 20188:08 amRNSHolding(s) in Company
30th Oct 20189:38 amRNSAGM Statement
30th Oct 20187:00 amRNSContract Win
19th Oct 201811:06 amRNSPosting of Annual Report and Registered Address
8th Oct 201810:36 amRNSHolding(s) in Company
5th Oct 201811:13 amRNSDirector/PDMR Shareholding
1st Oct 20188:24 amRNSFinal Results
27th Sep 201810:06 amRNSTrading Update
3rd Sep 20187:00 amRNSContract Win
25th Jul 201811:14 amRNSDirector/PDMR Dealing and Issue of Equity
23rd Jul 20187:00 amRNSBoard Appointment and Changes
16th Jul 20184:47 pmRNSHolding(s) in Company
3rd Jul 201812:25 pmRNSContract Win
26th Jun 20187:00 amRNSTrading Update
22nd May 20189:44 amRNSHolding(s) in Company
10th May 201811:07 amRNSHolding(s) in Company
3rd Apr 201811:15 amRNSHolding(s) in Company
28th Feb 201811:27 amRNSDirector/PDMR Shareholding
31st Jan 20187:00 amRNSHalf-year Report
28th Nov 20175:51 pmRNSHolding(s) in Company
2nd Nov 20178:29 amRNSHolding(s) in Company
17th Oct 20172:08 pmRNSPosting of Annual Report
27th Sep 20174:53 pmRNSDirector/PDMR Shareholding
15th Sep 20178:00 amRNSGrant of Options
31st Aug 20172:46 pmRNSDirector/PDMR Shareholding
30th Aug 20179:22 amRNSFinal Results
31st Jul 20177:00 amRNSContract Wins
12th Jul 20174:03 pmRNSHolding(s) in Company
17th May 20174:16 pmRNSHolding(s) in Company
16th May 20172:41 pmRNSDirector/PDMR Shareholding
16th May 201711:49 amRNSHolding(s) in Company
16th May 201711:46 amRNSHolding(s) in Company
15th May 20175:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.